Retrospective study to assess the efficacy and safety of checkpoint inhibitors in advanced urothelial carcinoma in real-world setting.

被引：0
|
作者：
Sevillano Fernandez, Elena
Puente, Javier
Vidal, Natalia
Pinto, Alvaro
Garcia Sanchez, Lourdes
Fiorini, Aldo
Chara Velarde, Luis Enrique
Nalda Ariza, Irene
Cassinello, Javier
Rodriguez, Angel
Galvan Ruiz, Saray
Francisco Rodriguez-Moreno, Juan
Barquin, Arantzazu
Ruiz, Sergio
Navarro, Paloma
Yague, Monica
Grande, Enrique
Garcia-Donas, Jesus
机构：
[1] HM Hosp, Madrid, Spain
[2] Hosp Univ Clin San Carlos, Madrid, Spain
[3] Hosp Clin San Carlos, Madrid, Spain
[4] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain
[5] Hosp Gen Segovia, Segovia, Spain
[6] Hosp Univ Guadalajara, Guadalajara, Spain
[7] Hosp Leon, Leon, Spain
[8] Hosp Univ Gran Canaria Doctor Negrin, Med Oncol Unit, Las Palmas Gran Canaria, Spain
[9] HM Hosp Ctr Integral Oncol Clara Campal, Madrid, Spain
[10] Lab Translat Oncol CIOCC, Madrid, Spain
[11] MD Anderson Canc Ctr, Madrid, Spain
[12] Fdn Hosp Madrid, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17043
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China
    Yang, Yang
    Tan, Lijie
    Hu, Jian
    Li, Yin
    Mao, Yousheng
    Tian, Ziqiang
    Zhang, Baihua
    Ma, Jianqun
    Li, Hecheng
    Chen, Chun
    Chen, Keneng
    Han, Yongtao
    Chen, Longqi
    Liu, Junfeng
    Yu, Bentong
    Yu, Zhentao
    Li, Zhigang
    DISEASES OF THE ESOPHAGUS, 2022, 35 (11)
  • [22] The effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitor (ICI) efficacy in patients with metastatic urothelial carcinoma (mUC) in real-world setting.
    Gupta, Shilpa
    Khan, Mohammad Siddique
    Radakovich, Nathan
    Wei, Wei
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Mian, Omar Y.
    Dawsey, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [23] Myositis with immune checkpoint inhibitors in a real-world setting
    Reactions Weekly, 2020, 1794 (1) : 11 - 11
  • [24] Immune checkpoint inhibitors as a real hope in advanced urothelial carcinoma
    Seront, Emmanuel
    Catala, Gaetan
    Dermine, Alexandre
    Lejeune, Sarah
    Rysselinck, Stephane
    FUTURE SCIENCE OA, 2018, 4 (10):
  • [25] Safety, adherence and efficacy of PCSK9 inhibitors: a retrospective real-world study
    Chng, Bee Ling Kelly
    Heng, Wei Min Paul
    Soon, Yu Ming
    Hon, Jin Shing
    Lau, Yee How
    Tan, Ru San
    Tan, Jack Wei Chieh
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2022, 31
  • [26] PEMBROBLAD: Real world effectiveness and safety of immune checkpoint inhibitors in patients with advanced urothelial carcinoma with histological variants.
    Amrane, Karim
    Campedel, Luca
    Bennamoun, Mostefa
    Gabriel, Pierre-Etienne
    Brouchet, Nicolas
    Pouessel, Damien
    Dugage, Matthieu Roulleaux
    Thibault, Constance
    Cancel, Mathilde
    Gout, Mathilde
    Flechon, Aude
    Huillard, Olivier
    Abbar, Baptiste
    Borchiellini, Delphine
    Doublet, Louis
    Augusto-Pelegrin, Laetitia
    Elouen, Boughalem
    Moinard-Butot, Fabien
    Dumont, Clement
    Barthelemy, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 624 - 624
  • [27] Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study
    Lushan Xiao
    Yanxia Liao
    Jiaren Wang
    Qimei Li
    Hongbo Zhu
    Chang Hong
    Ruining Li
    Jingzhe He
    Hao Cui
    Hanzhi Dong
    Lin Zeng
    Li Liu
    Cancer Immunology, Immunotherapy, 2023, 72 : 2299 - 2308
  • [28] Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors
    Khaki, Ali Raza
    Li, Ang
    Diamantopoulos, Leonidas N.
    Bilen, Mehmet A.
    Santos, Victor
    Esther, John
    Morales-Barrera, Rafael
    Devitt, Michael
    Nelson, Ariel
    Hoimes, Christopher J.
    Shreck, Evan
    Assi, Hussein
    Gartrell, Benjamin A.
    Sankin, Alex
    Rodriguez-Vida, Alejo
    Lythgoe, Mark
    Pinato, David J.
    Drakaki, Alexandra
    Joshi, Monika
    Isaacsson Velho, Pedro
    Hahn, Noah
    Liu, Sandy
    Alonso Buznego, Lucia
    Duran, Ignacio
    Moses, Marcus
    Jain, Jayanshu
    Murgic, Jure
    Baratam, Praneeth
    Barata, Pedro
    Tripathi, Abhishek
    Zakharia, Yousef
    Galsky, Matthew D.
    Sonpavde, Guru
    Yu, Evan Y.
    Shankaran, Veena
    Lyman, Gary H.
    Grivas, Petros
    CANCER, 2020, 126 (06) : 1208 - 1216
  • [29] Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study
    Xiao, Lushan
    Liao, Yanxia
    Wang, Jiaren
    Li, Qimei
    Zhu, Hongbo
    Hong, Chang
    Li, Ruining
    He, Jingzhe
    Cui, Hao
    Dong, Hanzhi
    Zeng, Lin
    Liu, Li
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2299 - 2308
  • [30] Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study
    Zengjun Liu
    Jing Xu
    Mengyao Liu
    Wenyu Hu
    Ni Xu
    Dongyuan Zhu
    Scientific Reports, 13
12345